[1]张峥.酪酸梭菌活菌散对支气管哮喘患儿辅助性T 细胞17、调节性T细胞及其相关细胞因子和肠道菌群的影响[J].新乡医学院学报,2023,40(1):050-54.[doi:10.7683/xxyxyxb.2023.01.009]
　ZHANG Zheng.Effect of Clostridium butyricum powder on helper T cell 17,regulatory T cells and their related cytokines and intestinal flora in children with bronchial asthma[J].Journal of Xinxiang Medical University,2023,40(1):050-54.[doi:10.7683/xxyxyxb.2023.01.009]
点击复制

酪酸梭菌活菌散对支气管哮喘患儿辅助性T 细胞17、调节性T细胞及其相关细胞因子和肠道菌群的影响
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
40卷
期数:
2023年1期
页码:
050-54
栏目:
临床研究
出版日期:
2023-01-05

文章信息/Info

Title:
Effect of Clostridium butyricum powder on helper T cell 17,regulatory T cells and their related cytokines and intestinal flora in children with bronchial asthma
作者:
张峥
（新乡医学院第三附属医院儿科，河南　新乡　453003）
Author(s):
ZHANG Zheng
(Department of Pediatrics,the Third Affiliated Hospital of Xinxiang Medical University,Xinxiang 453003,Henan Province,China)
关键词:
支气管哮喘; 酪酸梭菌活菌散; 辅助性T 细胞17; 调节性T细胞; 肠道菌群; 肺功能
Keywords:
bronchial asthma; Clostridium butyricum powder; helper T cell 17; regulatory T cell; intestinal flora; pulmonary function
分类号:
R725.6
DOI:
10.7683/xxyxyxb.2023.01.009
文献标志码:
A
摘要:
目的　探讨酪酸梭菌活菌散对支气管哮喘患儿辅助性T细胞17（Th17细胞）、调节性T细胞（Tr细胞）及其相关细胞因子和肠道菌群的影响。方法　选择2018年3月至2020年6月新乡医学院第三附属医院收治的97例支气管哮喘患儿为研究对象，根据治疗方法将患儿分为观察组（n=49）和对照组（n=48）。对照组患儿给予吸入用布地奈德混悬液、吸入用异丙托溴铵溶液和孟鲁司特钠颗粒治疗；在对照组治疗基础上，观察者组患儿给予酪酸梭菌活菌散治疗，2组患儿均治疗2个月。应用流式细胞仪检测2组患儿治疗前后Th17细胞和Tr细胞水平，并计算Th17细胞与Tr细胞的比值（Th17/Tr）；采用酶联免疫吸附试验检测2组患儿治疗前后血清中白细胞介素-17（IL-17）、白细胞介素-10（IL-10）水平。使用儿童肺功能仪检测2组患儿治疗前后第1秒用力呼气容积（FEV1）、FEV1/用力肺活量（FVC）、呼气流量峰值（PEF）日变异率；分别于治疗前后收集并培养2组患儿新鲜粪便，观察肠道菌群分布情况。治疗期间观察2组患儿不良反应发生情况，治疗后评估患儿临床疗效；所有患儿治疗后随访2个月，记录患儿每月哮喘急性发作次数。结果　治疗前2组患儿Th17/Tr及血清IL-17、IL-10水平比较差异无统计学意义（P>0.05）；与治疗前比较，治疗后2组患儿Th17/Tr、血清IL-17水平显著降低，血清IL-10水平显著升高（P<0.05）；治疗后，观察组患儿Th17/Tr和血清IL-17水平显著低于对照组，血清IL-10水平显著高于对照组（P<0.05）。治疗前2组患儿FEV1、FEV1/FVC、PEF日变异率比较差异无统计学意义（P>0.05）；与治疗前比较，治疗后2组患儿FEV1、FEV1/FVC显著升高，PEF日变异率显著降低（P<0.05）；治疗后，观察组患儿FEV1、FEV1/FVC显著高于对照组，PEF日变异率显著低于对照组（P<0.05）。治疗前2组患儿粪便中乳酸杆菌、酪酸梭菌、大肠杆菌、粪肠球菌的菌落数比较差异无统计学意义（P>0.05）；对照组患儿治疗前后粪便中乳酸杆菌、酪酸梭菌、大肠杆菌、粪肠球菌的菌落数比较差异无统计学意义（P>0.05）；观察组患儿治疗后粪便中乳酸杆菌、酪酸梭菌的菌落数显著多于治疗前，大肠杆菌的菌落数显著少于治疗前（P<0.05）；观察组患儿治疗前后粪便中粪肠球菌的菌落数比较差异无统计学意义（P>0.05）；治疗后，观察组患儿粪便中乳酸杆菌、酪酸梭菌的菌落数显著多于对照组，大肠杆菌的菌落数显著少于对照组（P<0.05）；治疗后2组患儿粪便中粪肠球菌的菌落数比较差异无统计学意义（P>0.05）。观察组和对照组患儿治疗总有效率分别为95.91%（47/49）、81.25%（39/48），观察组患儿治疗总有效率显著高于对照组（χ2=5.189，P<0.05）。观察组和对照组患儿每月哮喘急性发作次数分别为（0.42±0.24）、（0.84±0.33）次，观察组患儿每月哮喘急性发作次数显著少于对照组（P<0.05）。2组患儿治疗期间均未发生明显不良反应。结论　酪酸梭菌活菌散可以有效提高支气管哮喘患儿免疫功能，抑制炎症反应，调节肠道菌群平衡，改善患儿肺功能和临床症状。
Abstract:
Objective　To investigate the effect of Clostridium butyricum powder on helper T cell 17 (Th17 cell),regulatory T cell (Tr cell) and their related cytokines and intestinal flora in children with bronchial asthma.Methods　A total of 97 children with bronchial asthma admitted to the Third Affiliated Hospital of Xinxiang Medical University from March 2018 to June 2020 were selected as the study subjects,and the children were divided into observation group (n=49) and control group (n=48) according to the treatment methods.The children in the control group were treated with budesonide suspension for inhalation,ipratropium bromide solution for inhalation and montelukast sodium oral granules.On the basis of the treatment in the control group,the children in the observation group were treated with Clostridium butyricum powder.The children in both groups were treated for two months.The levels of Th17 cells and Tr cells of children in the two groups were detected by flow cytometry before and after treatment,and the ratio of Th17 cells to Tr cells (Th17/Tr) was calculated.The levels of serum interleukin-17 (IL-17) and interleukin-10 (IL-10) of children in the two groups were detected by enzyme-linked immunosorbent assay.The forced expiratory volume in the first second (FEV1),FEV1/forced vital capacity (FVC) and daily variation rate of peak expiratory flow (PEF) of children in the two groups were measured by pulmonary function tester before and after treatment.The fresh feces of children in the two groups were collected and cultured before and after treatment to observe the distribution of intestinal flora.The adverse reactions of children in the two groups were observed during the treatment,and the clinical efficacy was evaluated after treatment.All children were followed up for two months after treatment,and the number of acute asthma attacks per month was recorded.Results　There was no significant difference in Th17/Tr and serum IL-17,IL-10 levels of Children between the two groups before treatment (P>0.05).Compared with before treatment,the levels of Th17/Tr and serum IL-17 of children in the two groups decreased significantly after treatment,and the level of serum IL-10 increased significantly (P<0.05).After treatment,the levels of Th17/Tr and serum IL-17 of children in the observation group were significantly lower than those in the control group,and the level of serum IL-10 was significantly higher than that in the control group (P<0.05).There was no significant difference in the FEV1,FEV1/FVC and the daily variation rate of PEF of children between the two groups before treatment (P>0.05).Compared with before treatment,the FEV1 and FEV1/FVC of children in the two groups increased significantly,and the daily variation rate of PEF decreased significantly after treatment (P<0.05).After treatment,the FEV1 and FEV1/FVC of children in the observation group were significantly higher than those in the control group,and the daily variation rate of PEF was significantly lower than that in the control group (P<0.05).There was no significant difference in the number of colonies of Clostridium butyricum,Escherichia coli and Enterococcus faecalis in the feces of children between the two groups before treatment (P>0.05).There was no significant difference in the number of colonies of Lactobacillus,Clostridium butyricum,Escherichia coli and Enterococcus faecalis in the feces of children in the control group before and after treatment (P>0.05).Compared with before treatment,the number of colonies of Lactobacillus and Clostridium butyricum in the feces of children in the observation group increased significantly after treatment,while the number of colonies of Escherichia coli decreased significantly (P<0.05).There was no significant difference in the number of Enterococcus faecalis colonies in the feces of children in the observation group before and after treatment (P>0.05).After treatment,the number of colonies of Lactobacillus and Clostridium butyricum in the feces of children in the observation group was significantly higher than that in the control group,and the number of colonies of Escherichia coli was significantly lower than that in the control group (P<0.05).There was no significant difference in the number of Enterococcus faecalis colonies in the feces between the two groups after treatment (P>0.05).The total effective rate of children in the observation group and the control group was 95.91% (47/49) and 81.25% (39/48),respectively.The total effective rate of children in the observation group was significantly higher than that in the control group(χ2=5.189,P<0.05).The number of acute asthma attacks per month in the observation group and the control group was 0.42±0.24 and 0.84±0.33,respectively.The number of acute asthma attacks per month of children in the observation group was significantly lower than that in the control group (P<0.05).There was no obvious adverse reaction of children in the both groups during treatment.Conclusion　Clostridium butyricum powder can effectively improve the immune function,inhibit inflammatory reaction,regulate the balance of intestinal flora,and improve the lung function and clinical symptoms in children with bronchial asthma.

参考文献/References:

［1］　赵丽芳，李怡，王雯.微生态与支气管哮喘气道炎症及发病机制的研究进展［J］.国际呼吸杂志，2022，42（6）：453-457.
ZHAO L F,LI Y,WANG W.Advances in microecology and airway inflammation and pathogenesis of bronchial asthma［J］.Int J Respir,2022,42(6):453-457.
［2］　谢翠翠，刘志钟，刘威.3～6岁儿童支气管哮喘的临床特征及影响因素分析［J］.临床肺科杂志，2021，26（7）：1026-1029.
XIE C C,LIU Z Z,LIU W.Analysis of clinical characteristics and influencing factors of bronchial asthma in children aged 3-6 years old［J］.J Clin Pulm Med,2021,26(7):1026-1029.
［3］　蔡春琼，经廷森.儿童支气管哮喘治疗的研究进展［J］.医学综述，2020，26（5）：970-974.
CAI C Q,JING T S.Research progress in treatment of bronchial asthma in children［J］.Med Recapitulate,2020,26(5):970-974.
［4］　乔翠娥.沙丁胺醇与布地奈德联合用药方案治疗支气管哮喘急性发作的临床分析［J］.吉林医学，2021，42（1）：124-125.
QIAO C E.Clinical analysis of salbutamol combined with budesonide in the treatment of acute bronchial asthma［J］.Jilin Med J,2021,42(1):124-125.
［5］　佟训靓，张越，李燕明.肠道菌群与支气管哮喘的研究进展［J］.国际呼吸杂志，2021，41（22）：1756-1760.
TONG X L,ZHANG Y,LI Y M.Research advance in correlation between gut microbiome and bronchial asthma［J］.Int J Respir,2021,41(22):1756-1760.
［6］　何慧珍，刘玉玲，李晓倩.理气和胃剂敷脐联合酪酸梭菌活菌散对小儿红霉素输液后胃肠道反应的影响［J］.现代中西医结合杂志，2022，31（4）：528-531.
HE H Z,LIU Y L,LI X Q.Effects of Liqi Hewei agent for umbilical application combined with clostridium butyricum powders on gastrointestinal reactions after erythromycin infusion in children［J］.Mod J Integr Tradit Chin Western Med,2022,31(4):528-531.
［7］　ARIYOSHI T,HAGIHARA M,TAKAHASHI M,et al.Effect of Clostridium butyricum on gastrointestinal infections［J］.Biomedicines,2022,10(2):483-489.
［8］　中华医学会儿科学分会呼吸学组.儿童支气管哮喘诊断与防治指南（2016年版）［J］.中华儿科杂志，2016，54（3）：167-181.
RESPIRATORY GROUP OF PEDIATRICS BRANCH OF CHINESE MEDICAL ASSOCIATION.Guidelines for the diagnosis and prevention of bronchial asthma in children (2016 edition)［J］.Chin J Pediatr,2016,54(3):167-181.
［9］　中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南（2020年版）［J］.中华结核和呼吸杂志，2020，43（12）：1023-1048.
ASTHMA GROUP OF CHINESE THROACIC SOCIETY.Guidelines for bronchial asthma prevent and management(2020 edition)［J］.Chin J Tuberc Respir Dis,2020,43(12):1023-1048.
［10］　ABUL H M,PHIPATANAKUL W.Severe asthma in children:evaluation and management［J］.Allergol Int,2019,68(2):150-157.
［11］　MENNINI M,DAHDAH L,ARTESANI M C,et al.Probiotics in asthma and allergy prevention［J］.Front Pediatr,2017,31(5):165-174.
［12］　尚云飞，陈洁玉，朱立成.Thl7/Treg平衡与支气管哮喘的关系研究进展［J］.临床肺科杂志，2012，17（4）：699-700.
SHANG Y F,CHEN J Y,ZHU L C.Research progress on the relationship between Thl7/Treg balance and bronchial asthma［J］.J Clin Pulm Med,2012,17(4):699-700.
［13］　JIANG Y H,BAO C X,ZHAO X Y,et al.Intestinal bacteria flora changes in patients with Mycoplasma pneumoniae pneumonia with or without wheezing［J］.Sci Rep,2022,12(1):5683.
［14］　辛娜，李敬梅，王永锋，等.γ-分泌酶抑制剂在哮喘小鼠模型Th17/Treg平衡失调中的作用［J］.山西医科大学学报，2017，48（9）：918-921.
XIN N,LI J M,WANG Y F,et al.Role of γ-secretase inhibitor in the imbalance of Th17/Treg in a mouse asthmatic model［J］.J Shanxi Med Univ,2017,48(9):918-921.
［15］　阎娜，苏宝凤，陈峻峰.小儿哮喘患者外周血炎症因子IL-4、IL-17、IL-33对病情判断及与免疫功能、气道功能的相关关系［J］.解放军预防医学杂志，2019，37（8）：100-102.
YAN N,SU B F,CHEN J F.Correlation between peripheral blood inflammatory factors (IL-4,IL-17,IL-33) and immune function and airway function in children with asthma［J］.J Prev Med Chin PLA,2019,37(8):100-102.
［16］　LIU Y H,LIU C,AN K Y,et al.Effect of dietary clostridium butyricum supplementation on growth performance,intestinal barrier function,immune function,and microbiota diversity of pekin ducks［J］.Animals,2021,11(9):2514.
［17］　HAGIHARA M,ARIYOSHI T,KUROKI Y,et al.Clostridium butyricum enhances colonization resistance against Clostridioides difficile by metabolic and immune modulation［J］.Sci Rep,2021,11(1):15007.
［18］　广西医科大学第一附属医院.热灭活酪酸梭菌在作为和/或制备用于防治哮喘的产品中的应用：CN202210299769.2［P］.2022-05-10.
THE FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY.Application of heat-inactivated Clostridium caseinate in the prevention and treatment of asthma:CN202210299769.2［P］.2022-05-10.
［19］　袁琛，朱振刚.肠道菌群与哮喘关系的研究进展［J］.临床肺科杂志，2021，26（7）：1092-1096.
YUAN C,ZHU Z G.Research progress on the relationship between intestinal flora and asthma［J］.J Clin Pulm Med,2021,26(7):1092-1096.

相似文献/References:

[1]杜荣,郭悦鹏,陈永凤,等.误诊为支气管哮喘的气管肿瘤10例[J].新乡医学院学报,1996,13(01):090.
[2]张永辉,刘宗花,杜红丽,等.中药泡桐花浸膏对哮喘豚鼠肺组织作用的病理学研究[J].新乡医学院学报,2002,19(06):473.
[3]张永辉,宋伟涛,刘宗花,等.中药泡桐花浸膏防治支气管哮喘的实验性研究[J].新乡医学院学报,2002,19(03):186.
[4]王玉梅.联用沙丁胺醇和溴化异丙托品雾化吸入治疗支气管哮喘38例[J].新乡医学院学报,2002,19(04):314.
[5]张士奎,张道远.哮喘90 例对糖皮质激素气雾剂依从性调查[J].新乡医学院学报,2003,20(01):045.
[6]张士奎。 张道远.哮喘90例对糖皮质激素气雾剂依从性调查[J].新乡医学院学报,2003,20(01):046.
[7]王世英,忽新刚,吴春芳,等.支气管哮喘患者血清免疫球蛋白E和支气管肺泡灌洗液中白介素8测定及意义[J].新乡医学院学报,2009,26(01):056.
[8]陈　芳.小剂量罗红霉素对支气管哮喘患儿细胞免疫功能及炎症因子水平的影响[J].新乡医学院学报,2020,37(1):068.[doi:10.7683/xxyxyxb.2020.01.016]
　CHEN Fang.Effect of low-dose roxithromycin on cellular immune function and inflammatory factors in children with bronchial asthma[J].Journal of Xinxiang Medical University,2020,37(1):068.[doi:10.7683/xxyxyxb.2020.01.016]
[9]韩亚军,贾　新,王晓明.沙美特罗替卡松粉吸入剂联合氨茶碱注射液治疗老年支气管哮喘疗效观察[J].新乡医学院学报,2020,37(5):433.[doi:10.7683/xxyxyxb.2020.05.008]
　HAN Yajun,JIA Xin,WANG Xiaoming.Effect of salmeterol xinafoate and fluticasone propionate powder for inhalation combined with aminophylline injection in the treatment of elderly patients with bronchial asthma[J].Journal of Xinxiang Medical University,2020,37(1):433.[doi:10.7683/xxyxyxb.2020.05.008]
[10]曹利静,严东星,李林静,等.百令胶囊对支气管哮喘患者呼吸道重塑及肺功能的影响[J].新乡医学院学报,2019,36(5):475.[doi:10.7683/xxyxyxb.2019.05.018]
　CAO Li-jing,YAN Dong-xing,LI Lin-jing,et al.Effect of Bailing capsule on respiratory tract remodeling and pulmonary function in patients with bronchial asthma[J].Journal of Xinxiang Medical University,2019,36(1):475.[doi:10.7683/xxyxyxb.2019.05.018]

更新日期/Last Update: 2023-01-05